Literature DB >> 2834337

Molecular cloning and expression of the Bacillus anthracis edema factor toxin gene: a calmodulin-dependent adenylate cyclase.

M T Tippetts1, D L Robertson.   

Abstract

The Bacillus anthracis exotoxin is composed of a lethal factor, a protective antigen, and an edema factor (EF). EF is a calmodulin-dependent adenylate cyclase which elevates cyclic AMP levels within cells. The entire EF gene (cya) has been cloned in Escherichia coli, but EF gene expression by its own B. anthracis promoter could not be detected in E. coli. However, when the EF gene was placed downstream from the lac or the T7 promoter, enzymatically active EF was produced. The EF gene, like the protective antigen (pag) and lethal factor (lef) genes, was present on the large B. anthracis toxin plasmid pXO1.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2834337      PMCID: PMC211116          DOI: 10.1128/jb.170.5.2263-2266.1988

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  20 in total

1.  Production of toxin in vitro by Bacillus anthracis and its spearation into two components.

Authors:  C B THORNE; D M MOLNAR; R E STRANGE
Journal:  J Bacteriol       Date:  1960-03       Impact factor: 3.490

2.  Immunological screening method to detect specific translation products.

Authors:  S Broome; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

3.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

4.  Calmodulin activates prokaryotic adenylate cyclase.

Authors:  J Wolff; G H Cook; A R Goldhammer; S A Berkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

5.  Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin.

Authors:  J W Ezzell; B E Ivins; S H Leppla
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

6.  Bacillus anthracis calmodulin-dependent adenylate cyclase: chemical and enzymatic properties and interactions with eucaryotic cells.

Authors:  S H Leppla
Journal:  Adv Cyclic Nucleotide Protein Phosphorylation Res       Date:  1984

7.  Cloning of the protective antigen gene of Bacillus anthracis.

Authors:  M H Vodkin; S H Leppla
Journal:  Cell       Date:  1983-09       Impact factor: 41.582

8.  Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells.

Authors:  S H Leppla
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

9.  Demonstration of a capsule plasmid in Bacillus anthracis.

Authors:  B D Green; L Battisti; T M Koehler; C B Thorne; B E Ivins
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

10.  Evidence for plasmid-mediated toxin production in Bacillus anthracis.

Authors:  P Mikesell; B E Ivins; J D Ristroph; T M Dreier
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

View more
  18 in total

1.  atxA controls Bacillus anthracis capsule synthesis via acpA and a newly discovered regulator, acpB.

Authors:  Melissa Drysdale; Agathe Bourgogne; Susan G Hilsenbeck; Theresa M Koehler
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

Review 2.  Cyclic AMP in prokaryotes.

Authors:  J L Botsford; J G Harman
Journal:  Microbiol Rev       Date:  1992-03

3.  Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax.

Authors:  Melissa Drysdale; Sara Heninger; Julie Hutt; Yahua Chen; C Rick Lyons; Theresa M Koehler
Journal:  EMBO J       Date:  2004-12-16       Impact factor: 11.598

Review 4.  Rabbit and nonhuman primate models of toxin-targeting human anthrax vaccines.

Authors:  Andrew J Phipps; Christopher Premanandan; Roy E Barnewall; Michael D Lairmore
Journal:  Microbiol Mol Biol Rev       Date:  2004-12       Impact factor: 11.056

5.  Multicomponent anthrax toxin display and delivery using bacteriophage T4.

Authors:  Sathish B Shivachandra; Qin Li; Kristina K Peachman; Gary R Matyas; Stephen H Leppla; Carl R Alving; Mangala Rao; Venigalla B Rao
Journal:  Vaccine       Date:  2006-10-17       Impact factor: 3.641

Review 6.  Death at Sverdlovsk: what have we learned?

Authors:  D H Walker; O Yampolska; L M Grinberg
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

7.  Transcriptional regulation of the protective antigen gene of Bacillus anthracis.

Authors:  J M Bartkus; S H Leppla
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

8.  The roles of AtxA orthologs in virulence of anthrax-like Bacillus cereus G9241.

Authors:  Jennifer M Scarff; Malik J Raynor; Yuliya I Seldina; Christy L Ventura; Theresa M Koehler; Alison D O'Brien
Journal:  Mol Microbiol       Date:  2016-09-04       Impact factor: 3.501

9.  Cloning and characterization of a gene whose product is a trans-activator of anthrax toxin synthesis.

Authors:  I Uchida; J M Hornung; C B Thorne; K R Klimpel; S H Leppla
Journal:  J Bacteriol       Date:  1993-09       Impact factor: 3.490

10.  Anthrax edema toxin differentially regulates lipopolysaccharide-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cyclic AMP.

Authors:  D L Hoover; A M Friedlander; L C Rogers; I K Yoon; R L Warren; A S Cross
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.